BR112016002205A2 - filmes orodispersíveis - Google Patents

filmes orodispersíveis

Info

Publication number
BR112016002205A2
BR112016002205A2 BR112016002205A BR112016002205A BR112016002205A2 BR 112016002205 A2 BR112016002205 A2 BR 112016002205A2 BR 112016002205 A BR112016002205 A BR 112016002205A BR 112016002205 A BR112016002205 A BR 112016002205A BR 112016002205 A2 BR112016002205 A2 BR 112016002205A2
Authority
BR
Brazil
Prior art keywords
orodispersible films
orodispersible
films
disintegrant
plasticizer
Prior art date
Application number
BR112016002205A
Other languages
English (en)
Inventor
Filipa Silva Borges Ana
Margarida Almeida Silva Branca
Sousa Silva Cláudia
Fernando Jordão Coelho Jorge
Paulo Simões Sérgio
Original Assignee
Bluepharma Ind Farmaceutica S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bluepharma Ind Farmaceutica S A filed Critical Bluepharma Ind Farmaceutica S A
Publication of BR112016002205A2 publication Critical patent/BR112016002205A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)

Abstract

resumo "filmes orodispersíveis” aqui são apresentados filmes orodispersíveis que contêm um polímero formador de filme hidrofóbico, um desintegrante, um plastificante e um estabilizador.
BR112016002205A 2013-07-31 2014-07-31 filmes orodispersíveis BR112016002205A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361860516P 2013-07-31 2013-07-31
PCT/PT2014/000050 WO2015016727A2 (en) 2013-07-31 2014-07-31 Oral dispersible films

Publications (1)

Publication Number Publication Date
BR112016002205A2 true BR112016002205A2 (pt) 2017-08-01

Family

ID=51535496

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016002205A BR112016002205A2 (pt) 2013-07-31 2014-07-31 filmes orodispersíveis

Country Status (8)

Country Link
US (1) US9603935B2 (pt)
EP (1) EP3027172B1 (pt)
JP (1) JP6294479B2 (pt)
CN (1) CN105682639B (pt)
BR (1) BR112016002205A2 (pt)
ES (1) ES2835258T3 (pt)
HK (1) HK1225624A1 (pt)
WO (1) WO2015016727A2 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US10582915B2 (en) * 2015-11-25 2020-03-10 Tbm Company Film for oral hemostasis and wound protection
DK3442537T3 (da) * 2016-04-14 2024-03-25 Sensorion (+)-azasetron til anvendelse i behandlingen af ørelidelser
CN106619577A (zh) * 2016-10-08 2017-05-10 中国药科大学 一种新型氯雷他定口腔速溶膜及其制备方法
MY195591A (en) 2017-01-11 2023-02-02 Ferring Bv A Fast Disintegrating Pharmaceutical Composition
US11154585B2 (en) * 2017-01-18 2021-10-26 Pharmathen S.A. Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population
US20200197366A1 (en) * 2017-08-08 2020-06-25 Kashiv Biosciences, Llc Pharmaceutical composition comprising eliglustat
US11235013B2 (en) * 2018-09-04 2022-02-01 Babak Ghalili Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods
US11185526B2 (en) * 2018-09-04 2021-11-30 Babak Ghalili Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods
CN108785289A (zh) * 2018-09-06 2018-11-13 北京太阳升高科医药研究股份有限公司 盐酸那拉曲坦口溶膜剂及其制备方法
CN111166730A (zh) * 2018-11-13 2020-05-19 杨守忠 盐酸金刚烷胺的速释口溶膜及其制备方法和应用
IT201800020185A1 (it) * 2018-12-19 2020-06-19 Davide Fiumi Formulazioni contenenti vitamina d3 in film edibile per il trattamento di pazienti affetti da malassorbimento
CN109793201B (zh) * 2019-03-26 2022-08-09 武汉轻工大学 一种天然复合甜味剂及其制备方法和新型挤压面筋
CN112569208B (zh) * 2019-09-29 2023-10-31 四川科伦药物研究院有限公司 一种盐酸普拉克索药物组合物及其制备方法
US20210187858A1 (en) * 2019-12-18 2021-06-24 Dieu Cam Vuong Method and system for manufacturing of pharmaceutical formulas in form of orally disintegrating films (odf)
CN111388455B (zh) * 2020-04-09 2022-09-02 沈阳药科大学 一种依维莫司口腔膜剂及其制备方法
US20230330036A1 (en) * 2022-04-13 2023-10-19 Oak Therapeutics, Inc. Long acting, continuous oral release from oral dispersing strips (ods) addressing the need for high dosage of active ingredients
WO2023230430A1 (en) * 2022-05-21 2023-11-30 Neuvision Development Llc Topical ocular administration of ambroxol for ocular pain
CN114886877B (zh) * 2022-06-16 2024-02-02 北京海泰天正医药科技有限公司 奥氮平氟西汀复方口溶膜及其制备方法
CN114983984B (zh) * 2022-07-26 2023-09-01 山东达因海洋生物制药股份有限公司 一种用于哮喘治疗复方口溶膜剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2656338B2 (ja) * 1989-01-31 1997-09-24 日東電工株式会社 口腔粘膜貼付製剤
DE19961897A1 (de) * 1999-12-20 2001-06-28 Basf Ag Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
JP5701468B2 (ja) * 2001-10-12 2015-04-15 モノソル・アールエックス・エルエルシー 自己凝集しない均一な異種性を有する薄膜、その生成方法、およびそれから製造した薬物送達系
JP4879458B2 (ja) * 2001-10-12 2012-02-22 モノソル・アールエックス・エルエルシー 味マスキング組成物を含む迅速溶解剤形用の均一フィルム
MXPA05010422A (es) 2003-05-02 2005-11-04 Warner Lambert Co Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad.
CA2689594A1 (en) * 2007-06-07 2008-12-11 Sato Pharmaceutical Co., Ltd. Film preparation with rapidly dissolving property and flexibility
WO2010086989A1 (ja) 2009-01-29 2010-08-05 日東電工株式会社 口腔内フィルム状基剤及び製剤
EP2519226A1 (en) * 2009-12-28 2012-11-07 MonoSol Rx, LLC Orally administrable film dosage forms containing ondansetron
CN107693394A (zh) * 2010-12-23 2018-02-16 高露洁-棕榄公司 膜和包含所述膜的组合物

Also Published As

Publication number Publication date
EP3027172A2 (en) 2016-06-08
CN105682639B (zh) 2021-02-05
US9603935B2 (en) 2017-03-28
WO2015016727A3 (en) 2015-04-16
EP3027172B1 (en) 2020-09-16
US20150038594A1 (en) 2015-02-05
WO2015016727A4 (en) 2015-06-04
WO2015016727A2 (en) 2015-02-05
HK1225624A1 (zh) 2017-09-15
JP6294479B2 (ja) 2018-03-14
CN105682639A (zh) 2016-06-15
ES2835258T3 (es) 2021-06-22
JP2016525572A (ja) 2016-08-25

Similar Documents

Publication Publication Date Title
BR112016002205A2 (pt) filmes orodispersíveis
CL2016002772A1 (es) Composiciones de insulina de rápida acción
BR112017005381A2 (pt) composições que compreendem células recombinantes de bacillus e um inseticida.
BR112018069052A2 (pt) filme solúvel em água, embalagens que usam o filme e métodos de fabricação e uso dos mesmos
BR112017005507A2 (pt) composições que compreendem células recombinantes de bacillus e um fungicida.
BR112018072539A2 (pt) composições de epinefrina de administração aumentada
BR112017005504A2 (pt) composições que compreendem células recombinantes de bacillus e um inseticida.
EA201690613A1 (ru) Улучшенные составы на основе аденовирусов
BR112017005379A2 (pt) composições que compreendem células recombinantes de bacillus e um fungicida.
EP3520997A4 (en) WHITE FILM ROLL BASED ON HEAT SHRINK POLYESTER
BR112019004783A2 (pt) variantes de alfa-glicosidase ácida e usos das mesmas
BR112017028520A2 (pt) Sistemas adesivo de laminação - poliéster- policarbonato-poliol
EA201700136A1 (ru) Полимерная композиция для слоя элемента слоя
EP3394153A4 (en) HIGH POLYIMIDE POLYMER POLYMER FILM COMPOSITIONS
BR112017008154A2 (pt) construção de gerenciamento de luz
EA201700142A1 (ru) Полимерная композиция для слоя элемента слоя
EP3211460A4 (en) Light diffusion film
BR112016017609A2 (pt) Composição, e, processo
EP3163334A4 (en) Resin composition for optical applications, and film
BR112018007596A2 (pt) filme de polietileno que tem propriedades estéticas e de desempenho exclusivas
CL2019003456A1 (es) Copolimero de etileno que tiene propiedades de película mejoradas.
EP3546212A4 (en) HEAT-SHRINKABLE FILM, MACHINE-ORIENTED, HEAT-RESISTANT
BR112016009429A2 (pt) Filme de xiloglucano
EP3339000A4 (en) HEAT SHRINKABLE POLYESTER BASED FILM AND PACKAGING
BR112016015415A2 (pt) Filmes sobrelaminados

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time